Federal Register / Vol. 70, No.
91 / Thursday, May 12, 2005 / Notices
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Mental Health,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Institute of Mental
Health.
Date: June 12–14, 2005.
Time: 7 p.m. to 4:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Susan Koester, PhD,
Executive Secretary, Associate Director for
Science, Intramural Research Program,
National Institute of Mental Health, NIH,
Building 10, Room 4N222, MSC 1381,
Bethesda, MD 20892–1381. 301–496–3501.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: May 5, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–9498 Filed 5–11–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
constitute a clearly unwarranted
invasion of personal privacy.
VerDate jul<14>2003 19:04 May 11, 2005 Jkt 205001
25097
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel Clinical and Pediatric Research.
Date: May 23, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3AN12, Bethesda, MD 20892.
Contact Person: Helen R. Sunshine, PhD,
Chief, Office of Scientific Review, National
Institute of General Medical Sciences,
National Institutes of Health, Natcher
Building, Room 3AN–12F, Bethesda, MD
20892, 301–594–2881.
sunshinh@nigms.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: May 6, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–9500 Filed 5–11–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel Controller
Development for Upper Limb Movement.
Date: May 23, 2005.
Time: 8 a.m. to 5 p.m.
PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 E:\FR\FM\12MYN1.SGM
Agenda: To review and evaluate contract
proposals.
Place: Ramada Inn Rockville, 1775
Rockville Pike, Rockville, MD 20852.
Contact Person: Hameed Khan, PhD.,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, (301) 435–6902 Khanh@mail.nih,gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children,
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: May 6, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–9501 Filed 5–11–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group Digestive Diseases and
Nutrition C Subcommittee.
Date: June 23–24, 2005.
Open: June 23, 2005, 8 a.m. to 8:30 a.m.
12MYN1
 25098 Federal Register / Vol. 70, No. 91 / Thursday, May 12, 2005 / Notices
Agenda: To review procedures and discuss
policies.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Closed: June 23, 2005, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Closed: June 24, 2005, 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Paul A. Rushing, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 747, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–8895, rushingp@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: May 6, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–9503 Filed 5–11–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 05–70, Review R21s
(Genetics).
Date: June 14, 2005.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (telephone conference call).
VerDate jul<14>2003 19:04 May 11, 2005 Jkt 205001
Contact Person: H. George Hausch, PhD,
Acting Director, 45 Center Drive, Natcher
Building, Rm. 4AN44F, National Institutes of
Health, Bethesda, MD 20892 (301) 594–2904,
george_hausch@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 05–60, Review R25.
Date: June 30, 2005.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (telephone conference call).
Contact Person: Sooyoun (Sonia) Kim, MS,
Associate SRA, Scientific Review
Administrator, Scientific Review Branch,
Division of Extramural Research, National
Inst. of Dental & Craniofacial Research,
National Institute of Health, Bethesda, MD
20892, (301) 594–4827.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 05–58, Review R21s.
Date: July 14, 2005.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (telephone conference call).
Contact Person: Peter Zelazowski, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Activities, National Inst. of Dental &
Craniofacial Research, National Institutes of
Health, Bethesda, MD 20892–6402, (301)
593–4861. peter.zelazowski@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 05–66, Review of R21s
(Perio/Micro).
Date: July 18, 2005.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (telephone conference call).
Contact Person: Yujing Liu, MD, PhD,
Scientific Review Administrator, National
Institute of Dental & Craniofacial Res., 45
Center Drive, Natcher Building, Rm. 4AN38E,
Bethesda, MD 20892, (301) 594–3169,
yujing_liu@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 05–65, Review R21s (Oral
Cancer).
Date: July 19, 2005.
Time: 10:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (telephone conference call).
Contact Person: Peter Zelazowski, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Activities, National Inst. of Dental &
Craniofacial Research, National Institutes of
Health, Bethesda, MD 20892–6402, (301)
593–4861, peter.zelazowski@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 E:\FR\FM\12MYN1.SGM
Disorders Research, National Institutes of
Health, HHS)
Dated: May 6, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–9504 Filed 5–11–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; SBIR
II—‘‘Novel CBI Receptor Antagonists’’.
Date: May 25, 2005.
Time: 10 a.m. to 11 a.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852.
(Telephone Conference Call).
Contact Person: Eric Zatman, Contract
Review Specialist, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Room 220, MSC 8401, 6101
Executive Boulevard, Bethesda, MD 20892–
8401. (301) 435–1438.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
Dated: May 6, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–9508 Filed 5–11–05; 8:45 am]
BILLING CODE 4140–01–M
12MYN1